FDA tells GLP-1 makers to warn of potential vision loss side effect
The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”
Covered by 2 sources from United States. First reported by The Washington Post ·
How 2 newspapers cover this story
FDA tells GLP-1 makers to warn of potential vision loss side effect
The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
· GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says
Coverage details
2 outlets from United States are covering this story: The Washington Post and CBS News. The Washington Post published it first, on November 9, 2026; the last outlet to join was CBS News, 4 hours later.
Key names in the coverage: FDA.
In total 3 articles have been published, because some outlets updated the story several times.
